Anti-alpha-hemolysin monoclonal antibodies mediate protection against Staphylococcus aureus pneumonia

Keyphrases

• Monoclonal Antibody 100%
• Streptococcus Pneumoniae 100%
• Hemolysin 100%
• Epitope 50%
• Active Immunization 50%
• S. Aureus Pneumonia 50%
• Staphylococcal Pneumonia 50%
• Pneumonia 25%
• Murine Model 25%
• Virulence Factors 25%
• Amino Acids 25%
• Cell Injury 25%
• Cell Surface 25%
• Amino Acid Residues 25%
• Passive Immunization 25%
• Human Pathogens 25%
• Staphylococcus Aureus 25%
• Experimental Animals 25%
• Toxin Activity 25%
• Invasive Disease 25%
• Pore-forming 25%
• Antibody Therapy 25%
• Immunization Strategy 25%
• Cytotoxin 25%
• Human Lung Cells 25%
• Human Susceptibility 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Monoclonal Antibody 100%
• Staphylococcal Pneumonia 100%
• Alpha Hemolysin 100%
• Staphylococcus Aureus 75%
• Diseases 75%
• Amino Acid 50%
• Epitope 50%
• Pathogenesis 25%
• Experimental Animal 25%
• Virulence Factor 25%
• Cytotoxin 25%
• Oligomer 25%

Immunology and Microbiology

• Monoclonal Antibody 100%
• Staphylococcus Aureus 100%
• Hemolysin 100%
• Epitope 40%
• Active Immunization 40%
• Amino Acid 40%
• Virulence Factor 20%
• Target Cell 20%
• Cell Surface 20%
• Human Pathogen 20%
• Experimental Animal 20%
• Cell Damage 20%